Navigation Links
USF researchers identify gene mutation linked to old age hearing loss
Date:10/25/2012

TAMPA, Fla. (Oct. 25, 2012) - University of South Florida researchers have identified a genetic biomarker for age-related hearing loss, a major breakthrough in understanding and preventing a condition of aging that affects 30 million Americans and greatly diminishes their quality of life.

In a nine-year study that was a collaboration between USF's Global Center for Hearing & Speech Research and the National Technical Institute for the Deaf at the Rochester Institute of Technology, researchers were able to identify the first genetic biomarker for presbycusis. The genetic mutation carried by those who ultimately suffer from age-related hearing loss is linked to speech processing abilities in older people.

Their findings are published in the journal Hearing Research. The study was authored by USF College of Engineering professors Robert Frisina Jr. and Robert Frisina Sr., the founders of the Global Center for Hearing & Speech Research, and David Eddins, a USF associate professor of communication sciences and disorders and chemical and biological engineering.

In collaboration with the House Ear Institute in Los Angeles, the researchers discovered a gene that produces a key protein in the inner ear the cochlea called glutamate receptor metabotropic 7 (GRM7). The GRM7 protein is intimately involved in converting sound into the code of the nervous system, in the cochlea, which is then sent to the parts of the brain used for hearing and speech processing.

Now having identified the gene, the researchers said people can be tested and takes steps earlier in life such as avoiding loud noises, wearing ear protection and avoiding certain medicines known to damage hearing to protect their hearing.

"This gene is the first genetic biomarker for human age related hearing loss, meaning if you had certain configurations of this gene you would know that you are probably going to lose your hearing faster than someone who might have another configuration," said Robert Frisina Jr.

The Frisinas launched their study of genetics' role in hearing loss nine years ago in hopes of identifying the cause of one of the most common forms of permanent hearing loss. Clinically, age-related hearing loss has been defined as a progressive loss of sensitivity to sound, starting at the high frequencies, inability to understand speech, the lengthening of the minimum discernable temporal gap in sounds, and a decrease in the ability to filter out background noise. Researchers now know the causes of presbycusis are likely a combination of multiple environmental and genetic factors.

"Age-related hearing loss is a very prevalent problem in our society. It costs billions of dollars every year to manage and deal with it. It's right up there with heart disease and arthritis as far as being one of the top three chronic medical conditions of the aged," said Robert Frisina Jr.

DNA analyses were conducted and completed at the University of Rochester Medical School and the Rochester Institute of Technology.

The study involved 687 people who underwent three hours of extensive examination of their hearing capabilities, including genetic analyses and testing of speech processing.

Interestingly, the gene mutation played out differently in women than in men, the researchers found. While the variation had a negative impact for men, it did the opposite for women, who actually had better than average hearing in their elder years. That discovery supports a 2006 finding by the Frisina research group that the hormone aldosterone plays a role in hearing capabilities.
'/>"/>

Contact: Vickie Chachere
vchachere@usf.edu
813-974-6251
University of South Florida (USF Health)
Source:Eurekalert

Related biology news :

1. USDA scientists collaborate with global researchers to advance the mapping of the barley genome
2. Danish researchers release ground-breaking knowledge about calcium pumps in cells
3. CU-Boulder researchers uncover new target for cancer research
4. Columbia researchers report novel approach for single molecule electronic DNA sequencing
5. Researchers develop new stamping process to pattern biomolecules at high resolution
6. Mount Sinai researchers awarded Provocative Questions grant from National Cancer Institute
7. RUB researchers clarify catalysis mechanism of cell growth protein Ras
8. Researchers find our inner reptile hearts
9. Researchers develop rapid method to measure carbon footprints
10. Researchers reveal a chemo-resistant cancer stem cell as cancers Achilles heel
11. Researchers use banker plants to help battle whitefly pests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
Breaking Biology Technology: